{"id":"https://openalex.org/W2102000726","doi":null,"title":"Differential resistance of melanoma cells to treatment with recombinant IFN-alpha2b and leukocyte IFN.","display_name":"Differential resistance of melanoma cells to treatment with recombinant IFN-alpha2b and leukocyte IFN.","publication_year":2007,"publication_date":"2007-07-01","ids":{"openalex":"https://openalex.org/W2102000726","mag":"2102000726","pmid":"https://pubmed.ncbi.nlm.nih.gov/17695493"},"language":"en","primary_location":{"id":"pmid:17695493","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17695493","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002721999","display_name":"Kristina Ruuth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I90267481","display_name":"Ume\u00e5 University","ror":"https://ror.org/05kb8h459","country_code":"SE","type":"education","lineage":["https://openalex.org/I90267481"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Kristina Ruuth","raw_affiliation_strings":["Department of Molecular Biology, Ume\u00e5 University, 90187 Umea, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Biology, Ume\u00e5 University, 90187 Umea, Sweden","institution_ids":["https://openalex.org/I90267481"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077955002","display_name":"Asa Berglund","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Asa Berglund","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006113456","display_name":"Varinia Graciela Munoz-Ritchie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Varinia Munoz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5028650791","display_name":"Erik Lundgren","orcid":"https://orcid.org/0000-0001-8840-8067","observed_orcids":["https://orcid.org/0000-0001-8840-8067"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erik Lundgren","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3593,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.5792271,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"27","issue":"4B","first_page":"2109","last_page":"14"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.9106000065803528,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.9106000065803528,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.01759999990463257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.009800000116229057,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9020000100135803},{"id":"https://openalex.org/keywords/interferon-alpha-2b","display_name":"interferon alfa-2b","score":0.8489999771118164},{"id":"https://openalex.org/keywords/leukocyte-interferon","display_name":"leukocyte interferon","score":0.9440000057220459},{"id":"https://openalex.org/keywords/interferon-alpha-subtypes","display_name":"interferon-alpha subtypes","score":0.8320000171661377},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7850000262260437},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.847000002861023},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6209999918937683},{"id":"https://openalex.org/keywords/melanoma-cell-lines","display_name":"melanoma cell lines","score":0.7329999804496765},{"id":"https://openalex.org/keywords/interferon-receptor","display_name":"interferon receptor","score":0.6320000290870667}],"concepts":[{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.6517166495323181},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5847556591033936},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5812761783599854},{"id":"https://openalex.org/C2781228144","wikidata":"https://www.wikidata.org/wiki/Q6046441","display_name":"Interferon alfa","level":4,"score":0.5142588019371033},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4540844261646271},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4459003806114197},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.42772793769836426},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.4245620369911194},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.420929878950119},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.346038281917572},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.17223477363586426},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.1453169882297516},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11659067869186401}],"mesh":[{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048708","descriptor_name":"Cell Growth Processes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:17695493","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17695493","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"mag:2102000726","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17695493","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1965387829","https://openalex.org/W1970259496","https://openalex.org/W1979150053","https://openalex.org/W1982243836","https://openalex.org/W1986492501","https://openalex.org/W1990435553","https://openalex.org/W1993520606","https://openalex.org/W2022213389","https://openalex.org/W2025236720","https://openalex.org/W2049680888","https://openalex.org/W2049975068","https://openalex.org/W2075413744","https://openalex.org/W2076506898","https://openalex.org/W2087061049","https://openalex.org/W2102184637","https://openalex.org/W2122951893","https://openalex.org/W2148346149","https://openalex.org/W2159893604"],"related_works":["https://openalex.org/W2398205371","https://openalex.org/W2040587518","https://openalex.org/W2055088229","https://openalex.org/W2434177854","https://openalex.org/W3014049684","https://openalex.org/W1978497980","https://openalex.org/W2015441810","https://openalex.org/W2474052544","https://openalex.org/W138183151","https://openalex.org/W2441346947"],"abstract_inverted_index":{"BACKGROUND:":[0],"Interferon-alpha":[1],"(IFN-alpha)":[2],"subtypes":[3,157],"bind":[4],"to":[5,12,76,106,129,135,162],"the":[6,14,29,54,70,77,91,118,123],"same":[7,15,30],"receptor":[8],"and":[9,53,58,65,133],"are":[10],"expected":[11],"have":[13],"biological":[16],"functions.":[17],"Whether":[18],"or":[19],"not":[20],"leukocyte":[21,110,152],"IFN,":[22,52],"containing":[23,154],"six":[24,155],"major":[25,156],"IFN-alpha":[26,159],"proteins":[27],"had":[28],"anti-tumor":[31],"effect":[32,55],"as":[33,160],"one":[34],"subtype,":[35],"recombinant":[36],"IFN-alpha2b,":[37],"was":[38,60,97,113],"investigated.":[39],"MATERIALS":[40],"AND":[41],"METHODS:":[42],"Three":[43],"melanoma":[44,71],"lines":[45,73],"were":[46,74],"treated":[47,102,108],"with":[48,103,109,127,151],"both":[49,62,81],"types":[50],"of":[51,80,93,140,158],"on":[56],"proliferation":[57],"survival":[59],"estimated":[61],"after":[63],"short-term":[64,85],"prolonged":[66,89],"treatment.":[67,86],"RESULTS:":[68],"All":[69],"cell":[72],"sensitive":[75],"antiproliferative":[78],"effects":[79],"IFN":[82,125,153],"species":[83,126],"during":[84,148],"However,":[87],"upon":[88],"culture,":[90],"frequency":[92],"resistant":[94,119,141],"colony":[95],"formation":[96],"significantly":[98],"higher":[99],"in":[100],"cultures":[101],"IFN-alpha2b":[104],"compared":[105,161],"those":[107],"IFN.":[111],"There":[112],"a":[114,145],"qualitative":[115],"difference":[116],"between":[117],"colonies":[120],"selected":[121],"by":[122],"two":[124],"respect":[128],"morphology,":[130],"growth":[131],"rate":[132,147],"sensitivity":[134],"apoptosis.":[136],"CONCLUSION:":[137],"The":[138],"development":[139],"clones":[142],"occurred":[143],"at":[144],"lower":[146],"long-term":[149],"treatment":[150],"IFN-alpha2b.":[163]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}